Category Archives: new treatments

The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.

Posted on February 11, 2013 by Maurice Preter MD

Front Neurosci. 2012;6:33. doi: 10.3389/fnins.2012.00033. Epub 2012 Mar 26. The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy. Ruskin DN, Masino SA. Source Neuroscience Program, Department of Psychology, Trinity College Hartford, CT, USA. Abstract A link … Continue reading →

Posted in Complementary - Alternative Medicine, dietary, Events, Fifth Avenue Concierge Medicine, Health, keto, metabolic, new treatments, News, Psychiatry/Neurology | Tagged , , |

Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet.

Posted on February 11, 2013 by Maurice Preter MD

PLoS One. 2009 Dec 23;4(12):e8349. doi: 10.1371/journal.pone.0008349. Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. Ruskin DN, Kawamura M, Masino SA. Source Department of Psychology and Neuroscience Program, Trinity College, Hartford, Connecticut, United States of … Continue reading →

Posted in Complementary - Alternative Medicine, dietary, Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, metabolic, new treatments, News, Psychiatry/Neurology | Tagged , , |

Fingolimod treatment for multiple sclerosis patients What do we do with varicella?

Posted on January 16, 2013 by Maurice Preter MD

Fingolimod treatment for multiple sclerosis patie… [Ann Neurol. 2011] – PubMed – NCBI. Ann Neurol. 2011 Oct;70(4):673-4; author reply 674. doi: 10.1002/ana.22605. Fingolimod treatment for multiple sclerosis patients What do we do with varicella? Winkelmann A, Loebermann M, Reisinger EC, … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, keto, new treatments, Psychiatry/Neurology | Tagged , , , , |

Melanoma occurring during treatment with fingo… [Arch Dermatol. 2011] – PubMed – NCBI

Posted on January 16, 2013 by Maurice Preter MD

Arch Dermatol. 2011 Aug;147(8):991-2. doi: 10.1001/archdermatol.2011.212. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. Conzett KB, Kolm I, Jelcic I, Kamarachev J, Dummer R, Braun R, French LE, Linnebank M, Hofbauer GF. PMID: 21844470 [PubMed – … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, new treatments, Psychiatry/Neurology | Tagged , , , , |

Delayed fingolimod-associated asystole. [Mult Scler. 2011] – PubMed – NCBI

Posted on January 16, 2013 by Maurice Preter MD

Mult Scler. 2011 Nov;17(11):1387-9. doi: 10.1177/1352458511410344. Epub 2011 Jun 7. Delayed fingolimod-associated asystole. Espinosa PS, Berger JR. Source North Oaks Neurology, Hammond, LA, USA. ps.espinosa@gmail.com Abstract Oral fingolimod (Gilenya) is a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, keto, new treatments, Psychiatry/Neurology | Tagged , , |
Maurice Preter, MD

Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.